EDNA SMITH: Open Payments
NPI 1578692034 · WAIANAE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,220 in 50 payments from 11 companies in 2025. Trend: 2023 $477 · 2024 $867 · 2025 $1,220
Food & beverage: $1,220
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $289 |
| ABBVIE INC. | 8 | $184 |
| Otsuka America Pharmaceutical, Inc. | 6 | $183 |
| Neurocrine BioSciences, Inc. | 5 | $144 |
| Lundbeck LLC | 4 | $106 |
| Vanda Pharmaceuticals Inc. | 4 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $82 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: VRAYLAR, REXULTI, ARISTADA, INGREZZA, LYBALVI, ABILIFY MAINTENA, FANAPT, CAPLYTA.
Industry payments across HI — which companies pay providers there.
